Therapeutic potential of small interfering RNAs

Drugs of the Future

Volumn 29, Issue 7, 2004, Pages 741-750

  Sioud, Mouldy ^a  

^a Center of Clinical Epidemiology   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA;

APOPTOSIS; CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL GENETICS; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; EYE DISEASE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; LIVER FAILURE; MOLECULAR GENETICS; NONHUMAN; REVIEW; SEPSIS; VALIDATION PROCESS; VIRUS INFECTION;

EID: 4644295987     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.07.854171     Document Type: Review

References (76)

1. Hannon, G.J. RNA interference. Nature 2002, 418: 244-51.
2. Jorgensen, R. Altered gene expression in plants due to trans interaction between homologous genes. Trends Biotechnol 1990, 8: 340-4.
3. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391: 806-11.
4. Hamilton, A.J., Baulcombe, D.C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999, 286: 950-2.
5. Tuschl, T., Zamore, P.D., Lehmann, R., Bartel, D.P., Sharp, P.A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev 1999, 13: 3191-7.
6. Elbashir, S.M., Ledecknel, W., Tuschl, T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15: 188-200.
7. Sen, G.C. Viruses and interferons. Annu Rev Microbiol 2001, 55: 255-81.
8. Elbashir, S.M., Harborth, M.J., Ledecknel, W., Yalcin, A., Weber, K., Tuchl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-8.
9. Caplan, N.J., Parrish, S., Imani, F., Fire, A., Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001, 98: 9742-7.
10. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-97.
11. Lee, R.C., Feinbaum, R.L., Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75: 843-54.
12. Lee, R.C., Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294: 858-64.
13. Lim, L.P., Glasner, M.E., Yekta, S., Burge, C.B., Bartel, D.P. Vertebrate microRNA genes. Science 2001, 299: 154.
14. Hutvagner, G., Zamore, P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297: 2056-60.
15. Hammond, S.M., Boettcher, S., Gaudy, A.C., Kobayashi, R., Hannon, G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001, 293: 1146-50.
16. Calin, G.A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99: 15524-9.
17. Michael, M.Z., O'Connor, S.M., van Holst Pellekaan, N.G., Young, G.P., James, R.J. Reduced accumulation of specific microRNAs in colorectal neoplasis. Mol Cancer Res 2003, 1: 882-91.
18. Sioud, M., Røsok, Ø. Profiling microRNA expression using sensitive cDNA probes and filter arrays. Biotechniques 2004, In press.
19. Depicker, A., Van Montagu, M. Post-transcriptional gene silencing in plants. Curr Opin Cell Biol 1997, 9: 373-82.
20. Safinya, C.R. Structures of lipid-DNA complexes: Supramolecular assembly and gene delivery. Curr Opin Struct Biol 2001, 11: 440-8.
21. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000, 65: 271-84.
22. Sioud, M., Sørensen, D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Comm 2003, 312: 1220-5.
23. Brummelkamp, T.R. et al. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296: 550-3.
24. Miyagishi, M., Taira, K. U6 promoter-driven siRNA with four uridines 3'overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 2002, 19: 497-500.
25. Lee, N.S. et al. Expression of small interfering RNAs targeted against HIV-I rev transcripts in human cells. Nat Biotechnol 2002, 20: 500-5.
26. Shinagawa, T., Ishii, S. Generation of Ski-knockdown mice by expressing a long double-stranded RNA from an RNA polymerase II promoter. Genes Dev 2003, 17: 1340-5.
27. Shen, C. et al. Gene silencing by adenovirus-delivered siRNA. FEBS Lett 2003, 539: 111-4.
28. Rubinson, D.A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003, 33: 401-6.
29. Wiznerowicz, M., Trono, D. Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003, 77: 8957-61.
30. Thomas, C.E. et al. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4: 346-58.
31. Sioud, M. Nucleic acid enzymes as a novel generation of anti-gene agents. Curr Mol Med 2001, 1: 575-88.
32. Czauderna, F. et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 2003, 31: 2705-16.
33. Chiu, Y.L., Rana, T.M. siRNA function in RNAi: A chemical modification analysis. RNA 2003, 9: 1034-48.
34. Braasch, D.A. et al. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 2003, 42: 7967-75.
35. Gewirtz, A.M., Sokol, D.L., Ratajczak, M.Z. Nucleic acid therapeutics: State of the art and future prospects. Blood 1998, 92: 712-36.
36. Sioud, M. Therapeutic siRNAs. Trends Pharmacol Sci 2004, 25: 22-4.
37. Bullock, A.N., Fersht, A.R. Rescuing the function of mutant p53. Nat Rev Cancer 2001, 1: 68-76.
38. Brummelkamp, T.R. et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002, 2: 243-7.
39. Scherr, M. et al. Specific inhibition of brc-abl gene expression by small interfering RNA. Blood 2003, 101: 1566-9.
40. Wilda, M. et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002, 21: 5716-24.
41. Tsuruo, T. et al. Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal. Cancer Sci 2003, 94: 15-21.
42. Wu, H. et al. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003, 63: 1515-9.
43. Golstein, P. Controlling cell death. Science 1997, 275: 1081-2.
44. Wacheck, V. et al. Small interfering RNA targeting bcl-2 sensitized malignant melanoma. Oligonucleotides 2003, 15: 393-400.
45. Reich, S.J. et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003, 9: 210-6.
46. Jacque, J.M. et al. Modulation of HIV-1 replication by RNA interference. Nature 2002, 896: 1-4.
47. Cobum, G.A., Cullen, B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002, 76: 9225-31.
48. Martinez, M.A. et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002, 16: 2385-90.
49. Novina, A. et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002, 8: 681-6.
50. Gitlin, L., Karelsky, S., Andino, R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002, 418: 430-4.
51. Das, A.T. et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004, 78: 2601-5.
52. Song, E. et al. RNA interference targeting Fas protects mice from fulminate hepatitis. Nat Med 2003, 9: 347-51.
53. Zender, L. et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 2003, 100: 7797-802.
54. Sorensen, D.R. et al. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003, 327: 761-6.
55. Coussens, L.M., Werb, Z. Inflammatory cells and cancer: Think different. J Exp Med 2001, 193: F23-6.
56. Aharinejad, S. et al. Colony-stimulating factor-1 blockage by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 2004, In press.
57. Verma, U.N., Surabhi, R.M., Schmaltieg A., Becerra, C., Gaynor, R.B. Small interfering RNAs directed against â-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003, 9: 1291-300.
58. Carmell, M.A., Zhang, L., Conklin, D.S., Hannon, G.J., Rosenquist, T.A. Germline transmissions of RNAi in mice. Nat Struct Biol 2003, 10: 91-2.
59. Blobe, G.C., Obeid, L.M., Hannun, H.A. Regulation of protein kinase C and role in cancer biology. Cancer Met Rev 1994, 13: 411-31.
60. Sioud, M., Sørensen, D.R. A nuclease-resistant protein kinase Cα ribozyme blocks glioma cell growth. Nat Biotechnol 1998, 16: 556-61.
61. Leirdal, M., Sioud, M. Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem Biophys Res Comm 2002, 295: 744-8.
62. Leirdal, M., Sioud, M. Gene-array analysis of glioma cells after treatment with an anti-PKCα siRNA. In: Methods in Molecular Biology, Vol. 252. Ribozymes and siRNA Protocols. M. Sioud (Ed.). Humana Press: Totowa, 2004, 493-9.
63. Jackson, A.L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003, 21: 635-7.
64. Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 2003, 100: 6347-52.
65. Persengiev, S.P., Zhu, X., Green, M.R. Nonspecific, concentration- dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 2004, 10: 12-8.
66. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S., Khvorova, A. Rational siRNA design for RNA interference. Nat Biotechnol 2004, 10: 1-5.
67. Suzuki, K. et al. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci USA 1999, 96: 2285-90.
68. Fraser, A.G. et al. Functional genomic analysis of C. elegans chromosome I by systemic RNA interference. Nature 2000, 408: 325-30.
69. Sen, G., Wehrman, T.S., Myers, J.W., Blau, H.M. Restriciton enzyme-generated siRNA (REGS) vectors and libraries. Nat Genet 2004, 36: 183-9.
70. Shirane, D., Sugao, K., Namiki, S., Tanabe, M., Iino, M., Hirose, K. Enzymatic production of RNAi libraries from cDNAs. Nat Genet 2004, 36: 190-6.
71. Sioud, M., Wälchli, S. Strategies for generation of random siRNA libraries for functional gene analysis. In: Methods in Molecular Biology, RNA-Mediated Gene Silencing. G. Carmichael (Ed.). Humana Press: Totowa, In press.
72. Zheng, L. et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci USA 2004, 101: 135-40.
73. De Backer, M.D. et al. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans. Nat Biotechnol 2001, 19: 235-41.
74. Kawasaki, H., Onuki, R., Suyama, E., Taira, K. Identification of genes that function in the TNF-α-mediated apoptotic pathway using randomized hybrid ribozyme libraries. Nat Biotechnol 2002, 20: 376-80.
75. Chakrabordi, S., Sriram, B., Banerjea, A.C. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries. In: Methods in Molecular Biology, Vol. 252. Ribozymes and siRNA Protocols. M. Sioud (Ed.). Humana Press: Totowa, 2004, 279-90.
76. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425: 415-9.